PHELINUN® 200 mg (melphalan) as conditioning treatment prior to allogeneic haematopoietic stem cell transplantation in haematological diseases.
Multiple indications in metastatic breast cancer, early breast cancer and metastatic gastric cancer
Multiple indications in Non-Hodgkin's lymphoma (NHL), Chronic lymphocytic leukaemia (CLL), Rheumatoid arthritis, Granulomatosis with polyangiitis and microscopic polyangiitis and Pemphigus vulgaris